Skip to main content
PLOS One logoLink to PLOS One
. 2022 Dec 15;17(12):e0279023. doi: 10.1371/journal.pone.0279023

Intraoperative complications of cataract surgery using a low-energy femtosecond laser: Results from a real-world high-volume setting

Julia Riemey 1,*, Catharina Latz 1, Alireza Mirshahi 1
Editor: Rajiv Janardhanan2
PMCID: PMC9754167  PMID: 36520860

Abstract

In this study, we report data on intraoperative complications occurring after cataract surgery in a high-volume single-center setting using a low-energy, mobile femtosecond laser. We retrospectively reviewed the medical records of patients who underwent femtosecond laser-assisted cataract surgery (FLACS) in our hospital between August 2015 and December 2019. Among the sample of 1,806 eyes of 1,131 patients (903 left and 903 right eyes), the mean age was 75.8 years (range, 21–99 years). The overall intraoperative complication rate was 0.28% (n = 5), with three cases of anterior capsule tear (0.17%) and two cases of posterior capsule tear (0.11%). No further complications occurred. This study underlines the safety of low-energy femtosecond-assisted cataract surgery in a real-world setting with a very low rate of intraoperative complications.

Introduction

Cataract surgery is one of the most frequently performed procedures in the world [1, 2]. A round, well-centered, and reproducible capsulotomy is essential for successful cataract surgery and intraocular lens (IOL) implantation [1]. The femtosecond laser-assisted technique is special and unique because it allows tissue inside the eye to be cut with very high precision [3]. Femtosecond laser-assisted cataract surgery (FLACS) has enabled cataract surgeons to eliminate the inherent imprecision of manual anterior capsulorhexis techniques and has therefore become a useful tool in cataract surgery in the past decade [1, 4]. As compared with manual capsulorhexis, capsulotomies performed with a femtosecond laser are expected to have less variation in centration and size with reproducible, uniform circular and accurate diameters [1]. Precise, safe, and reproducible capsulotomy is a prerequisite for successful cataract surgery and IOL implantation. Capsulotomies that are performed with a femtosecond laser lead to a more effective lens positioning with reduced probability of IOL tilt and decentration [4].

The latest improvement in femtosecond lasers is the use of low energy. Low-energy technology is a particularly gentle method: while the cutting process is driven by mechanical forces with the high-pulse-energy laser, the tissue can be effectively separated without the need for secondary mechanical tearing effects [3]. Therefore, using low pulse energy results in a very smooth surface, and the adjacent tissue remains virtually undamaged [3]. A high-pulse-energy uses larger spacing between spots, whereas a low-pulse-energy laser allows creation of a larger number of overlapping smaller spots [3]. Recent changes in the numerical aperture of laser-focusing optics and the repetition rate of laser sources have further decreased collateral damage while increasing precision. By enlarging the numerical aperture of the focusing optics, the pulse energy threshold for optical breakdown decreases, resulting in cutting with almost little collateral damage.

Publications reporting the results of low-energy lasers are still very sparse. In this study, we report data on the intraoperative complications of cataract surgery using a low-energy femtosecond laser in a high-volume single-center setting in Bonn, Germany. in this study, we examine the intraoperative complication rate of FLACS performed by one of two experienced surgeons.

Materials and methods

This was a retrospective, single-center, consecutive case series. We reviewed the medical records of patients who underwent low-energy FLACS with Ziemer LDV Z8 (Ziemer Ophthalmic Systems AG, Port, Switzerland) between August 1, 2015, and December 31, 2019. Unlike most femtosecond lasers, the Ziemer FEMTO LDV Z8 uses low pulse energy (nJ) and a high repetition rate in the MHz range. All patients underwent an operation at the Dardenne Eye Hospital (Bonn, Germany), which was performed by two experienced high-volume cataract surgeons (A.M., K.T.). The first 20 operations performed by each surgeon were considered learning experience and as such were excluded from the analysis. We reviewed the surgery reports with special attention paid to the occurrence of intraoperative complications, including but not limited to capsular complications during FLACS. An intraoperative complication existed when the surgery report was marked as “impeded with complications.” In case of a complication, we collected further data concerning patient demographics, additional ocular diagnoses, ocular biometry, and the outcome. Observational data were calculated using Excel (Microsoft Office Professional Plus 2013). We calculated the complication rate and confidence limits using the RStudio 1.4.1717 two-sided exact binomial test, assuming that the complication rate was not zero. This study was performed according to the tenets of the Declaration of Helsinki and did not require approval of an independent ethics committee, as ruled by the North Rhine Medical Chamber, due to the retrospective and epidemiological design as stated in §15 of the code of medical ethics by the North Rhine Chamber of Physicians. All included patients were aware of the use of their data for research purposes. Informed consent was waived.

Femtosecond laser

Femtosecond lasers are a more recent advance in solid-state laser technology. These lasers operate at near-infrared wavelengths at pulse durations of less than 1 picosecond (ps). Because the threshold radiant exposure (J/cm2) for inducing optical breakdown in tissue is about two orders of magnitude lower in the femtosecond (fs) pulse duration regime than at 10 nanoseconds (ns) [5], much lower pulse energies can be applied to separate tissue. High pulse repetition rates from 10 s of kHz to even MHz are then used to create continuous cut planes inside the tissue, by placing many pulses close to each other with the help of three-dimensional focus scanner beam scanning systems.

Lower pulse energies lead to a drastic reduction in the mechanical side effects of optical breakdown. For 300-fs pulses of 0.75-μJ energy, the generated cavitation bubbles have radii of only 45 μm, almost two orders of magnitude smaller than ns pulse with energies in the mJ range [6]. In addition, the associated pressure waves are much weaker, 1–5 bar at 1 mm distance [7]. This process is referred to as “plasma-induced ablation,” as the disruptive mechanical side effects of ns pulses are basically absent. In addition, the thermal side effects of fs pulses in tissue are almost negligible [8].

The pulse energy required to achieve optical breakdown can be reduced in two ways. First, by shortening the pulse duration—the latest fs lasers can achieve pulse durations of 200–300 fs, whereas earlier models had pulse durations of up to 800 fs. Second, by reducing the focal spot size and the beam waist. In other words, the focal volume varies inversely with the cube of the numerical aperture of the focusing optics. The larger the numerical aperture, the smaller the focal spot and, finally, the smaller the energy threshold for optical breakdown [9].

Surgical technique

Almost all surgeries were performed under peribulbar anesthesia (4 mL bupivacaine 0.75% and 2 mL mepivacaine 2% + 75 IE hyaluronic acid). In cases with increased risk of bleeding (i.e., continuous anticoagulation), the surgery was performed under topical anesthesia. Following disinfection, the eye was draped in a sterile manner. A Lieberman speculum was used, and the Ziemer FEMTO LDV Z8 suction ring was applied to the eye. If needed, the speculum was further widened or placed at an angle to allow for optimized suction. Once a vacuum was achieved, the patient interface was securely attached to the eye. Next, 2–5 mL of balanced salt solution (BSS) was applied to the patient interface, and the femtosecond handpiece was docked. Attention was then focused on the femtosecond laser monitor. Capsulotomy size and position, as well as lens fragmentation location, were suggested automatically by the laser or adjusted according to the patient’s individual optical coherence tomography (OCT) images, if needed. The standard preset was a 5.2-mm-diameter capsulotomy centered on the pupil with 95% laser energy and nuclear fragmentation with a 6-mm diameter in an eight-segment pattern with 110% laser energy. After capsulotomy and fragmentation were complete, the vacuum was released, and the laser handpiece was removed. Next, a clear corneal or near-clear corneal tunnel of 2.4-mm width and approximately 2.5-mm length was placed at either the 12 o’clock or temporal position. A dispersive viscoelastic was used to fill the anterior chamber, and two paracenteses of 0.9 mm each were placed. Next, the integrity of the capsulotomy was controlled with Utrata forceps, and the precut anterior capsule was removed from the anterior chamber. To mobilize the nucleus, gentle hydrodissection and hydrodelination were performed. The 2.4-mm phacotip (Centurion, Alcon, Freiburg, Germany) was introduced through the corneal tunnel, and a chopper was introduced through the side port. Nuclear disassembly was performed by mechanically separating and aspirating the precut pieces. The epinucleus was rotated and removed using low phaco and moderate vacuum settings. The cortex was aspirated using the bimanual irrigation/aspiration (I/A) system. The capsule was polished by jet irrigation with BSS. The IOL was implanted into the capsular bag either with viscoelastic stabilization or, if the IOL was shootable, under irrigation. The IOL was centered, and the optimal position of the optic and haptics was controlled. The remaining viscoelastic was removed with the I/A handpieces. The wounds were hydrated and checked for water tightness. 1 mg cefuroxim was administered intracamerally in addition to subconjunctival dexamethasone 1 mL (4 mg/mL), as well as subtenonal triamcinolone 1 mL (40 mg/mL). The speculum was removed, and ofloxacin ointment was introduced to the fornix. The eye was dressed with an eye bandage.

Results

We reviewed the records of 1,806 eyes of 1,131 patients (Table 1). A total of 903 left eyes and 903 right eyes were operated by either of two experienced cataract surgeons. The patients were on average 75.7 years old, with a minimum age of 21 years and a maximum age of 99 years.

Table 1. Overview of the patient sample.

Sample Complication cases
Patients 1,131 5
Eyes 1,806 5
Right eye 903 1
Left eye 903 4
Mean age, years 75.75 78.00
Age, years (minimum) 21 56
Age, years (maximum) 99 89

Among the study sample, intraoperative complications occurred in five eyes of five patients, which correspond to a complication rate of 0.28% (95% confidence interval 0.09%–0.65%, p < 0.05; see Table 2). All complications were capsule related: three eyes had an anterior capsular tear (0.17%), whereas the other two eyes had a posterior capsule rupture (0.11%). We did not experience any suction losses. IOL implantation was successful in all cases (100%). In three of the five cases (60%), the IOL could be implanted into the capsular bag. Sulcus implantation was performed in two cases (40%) with posterior capsular tears. Anterior vitrectomy was required in one case of posterior capsular rupture.

Table 2. Overview of complication cases.

n (%)
Complication 5 (0.28)
Anterior capsular tear 3 (0.17)
Posterior capsule rupture 2 (0.11)
Successful implantation of IOL 5 (100)
 In the capsular bag 3 (60)
 In the sulcus 2 (40)

For the sake of completeness, we also present the number of complications considering the first 20 surgeries of each surgeon. An additional two complications were observed among the initial 20 cases of each surgeon, for a total of seven complications reported among 1,846 of the operated eyes. The subsequent complications occurred in surgery numbers 106, 383, 476, 891, and 1,416.

Patients with complications were on average 78.00 years old. The youngest patient experiencing a complication was 56 years old, while the oldest person with a complication was 89 years old. Four complications occurred when operating the right eyes; one complication appeared in the left eye. Each patient with a complication had at least one diagnosis aggravating surgery: hard nucleus (3), posterior subcapsular cataract (1), primary posterior capsular fibrosis (1), floppy iris (1), narrow pupil (1), flat anterior chamber (1), and positive posterior pressure (2) (see Table 3). None of the patients suffered from diabetes or were taking prostate medication.

Table 3. Diagnoses aggravating surgery in patients with an intraoperative complication.

Patient
Complication 1 2 3 4 5 Sum
Hard nucleus x x x 3
Posterior subcapsular opacity x 1
Primary posterior capsular Fibrosis x 1
Floppy iris x 1
Narrow pupil x 1
Flat anterior chamber x 1
Positive posterior pressure x x 2
Sum 2 2 1 3 2

Discussion

The results of our study underline the safety of low-energy FLACS in a high-volume, real-world setting. The only observed complications were capsule related, and those occurred at a very low incidence rate of 0.28%. Among many factors that could influence the complications rates in cataract surgery, two should be emphasized: (1) both surgeons who performed the surgeries in this study were high-volume surgeons (>15,000 cases in total and >1,000 cases per year), potentially resulting in a lower intraoperative complication rate as compared with nonexperienced surgeons, and (2) the use of a low-energy femtosecond laser proved to be safe in our case series.

Intraoperative complications in low- and high-energy FLACS

Numerous studies have reported the results of FLACS with high-energy femtosecond laser. In a large meta-analysis, Popovic et al. [10] observed an overall incidence of complications of 379 events in a total of 3,704 eyes, corresponding to a complication rate of 10.23%.

The high-energy method generates more stress or potentially even damage to the adjacent tissue [3]. Compared with the high-energy concept, the low-energy method generates a uniquely smooth surface, which hardly damages the adjacent tissue at all [3]. This results in lower amounts of intraoperative prostaglandin release and, thereby, no or negligible intraoperative pupil narrowing [11]. An increased level of prostaglandin may be responsible for the intraoperative narrowing of the pupil [11]. Findings of Schwarzenbacher et al. [12] underline that the low-energy concept produces a negligible inflammatory response: inflammatory cytokines interleukin (IL)-1b and IL-6 were not elevated after pretreatment with low-energy femtosecond laser [12]. In another study including 52 eyes that had undergone FLACS, no statistically significant changes were detected in the pupil area when comparing preoperative pupil status with postlaser size [11].

Literature on the use of the low-energy laser is still very sparse. Recently, Lin et al. [13] reported comparative results of a low- versus high-energy FLACS in 200 eyes of 200 patients. While the incision completeness and side incisions were comparable between the two groups, the low-energy device delivered better integrity of capsulotomies, with less intraoperative pupil narrowing [13]. Existing studies have all reported no major intraoperative complications using the low-energy laser [1417]. In a study with 14 eyes undergoing high-frequency, low-energy FLACS, no major complications, such as anterior capsule tears or posterior capsule ruptures, occurred [16]. In comparing low-energy FLACS with standard phacoemulsification, Cavallini et al. [14] did not observe any major intraoperative complications. In the low-energy group consisting of 70 eyes, the incision was incomplete in two cases; no incomplete capsulotomies were reported [14]. These findings are congruent with our results: based on a much larger sample size (1,806 eyes), we observed a comparatively low complication rate. Hence, one side effect of lower “collateral damage” when using the low-energy method may be less complicated surgeries.

Capsule complications in FLACS

Because we observed only capsule complications in our study, it is worthwhile to take a closer look at this specific type of complication with regard to FLACS.

In the beginning of FLACS technology, the integrity of laser anterior capsulotomy was reported to be compromised as compared with phacoemulsification capsulotomy, because of aberrant pits that created postage-stamp perforations [18]. The quality of the laser capsulotomy has been improved since then: the smoothness of the capsulotomy edge was improved by decreasing the spot size and separation. In addition, the overall time it takes to complete a laser capsulotomy and nuclear fragmentation has been reduced. Moreover, the impact of the laser energy not only on the capsulotomy but also on the epithelial cells of the lens has been further evaluated [1921]. Pulse energies of 13 μJ and higher showed significantly more inflammation and apoptosis in lens epithelial cells when compared with either manual rhexis or pulse energies of 10 μJ or less [19, 20]. With the low-energy, high-frequency system, pulse energies range from 103 lower. Here when different energy levels of 90%, 130%, and 150% were compared, apoptosis was not increased in a dose-dependent manner [22]. In addition, capsulotomy strength was not significantly different across the three different energy settings [22]. Thus, a very low rate of capsule tears has been reported for the Ziemer FEMTO LDV Z8 (see Table 4). In 2020, Kolb et al. [17] published a meta-analysis and systematic review in which 218 eyes were treated with the low-energy Ziemer FEMTO LDV Z8, and no anterior or posterior capsular tears occurred [17]. With the high-energy laser, 78 events of anterior capsular tear occurred in 7,804 eyes (1.00%) and 30 events of posterior capsule rupture occurred in 6,973 eyes (0.43%) [17]. Wang et al. [23] and Popovic et al. [10] also reported a capsule complication rate of 2.35% and 5.27%, respectively, for high-energy FLACS, whereas Pajic et al. [15] reported no major capsular complications with the use of a low-energy device.

Table 4. Capsule complication rates by femtosecond laser device in different publications.

Femtosecond laser device Posterior capsule complication rate Anterior capsule complication rate Capsule complication rate
Popovic et al. (2016) High energy 0.89%
(n = 3,390)
Not reported 5.27%
(n = 3,571)
Kolb et al. (2020) High energy 0.43%
(n = 6,973)
1.00%
(n = 7,804)
1.38%
(n = 7,837)
Wang et al. (2019) High energy 0.62%
(n = 3,080)
1.77%
(n = 3,113)
2.35%
(n = 3,153)
Pajic et al. (2017) Low energy Not reported Not reported 0.00%
(n = 68)
Kolb et al. (2020) Low energy 0.00%
(n = 218)
0.00%
(n = 218)
0.00%
(n = 218)
Our study Low energy 0.11%
(n = 1,806)
0.17%
(n = 1,806)
0.28%
(n = 1,806)

In accordance with the few reported capsular complications in the low-energy setting, our study included a much larger sample size with similarly low capsule complications. While performing FLACS with the Ziemer FEMTO LDV Z8, we noticed that the integrity of the capsulotomy was substantially higher when the aimed capsulotomy position was moved anteriorly in relation to the OCT-measured capsule position. We hypothesized that the nuclear fragmentation prior to capsulotomy caused an anteriorization of the lens capsule apparatus by creating gas bubbles inside the lens capsule complex.

FLACS in comparison with phacoemulsification

An insight into the results published in the scientific literature will provide an overview regarding how the operative outcomes of FLACS compare with those of standard phacoemulsification. According to published studies, the two procedures do not differ in terms of visual and refractive outcomes or in overall [10] or intra- and postoperative complication rates [23]. However, Chen et al. [24] reported a statistically significant lower rate of intraoperative complications (1.8%) in FLACS subjects in comparison with subjects undergoing the traditional phacoemulsification technique (5.8%), investigating 273 eyes and 553, respectively. Complication rates using the high-energy laser device ranged from 0% in three surgeons; to 1.8% and 2.4% in another two surgeons, respectively; and up to 5.8% in one surgeon. Four of five surgeons in the study had a lower complication rate when conducting the laser-assisted procedure. An open posterior capsule occurred two times in FLACS, whereas it occurred 10 times in traditional phacoemulsification [24]. For FLACS, this corresponds to a posterior capsule complication rate of 0.73. Referring to this result, in our study posterior capsule complication rate was lower, at 0.11%.

In comparing low-energy FLACS using Ziemer FEMTO LDV Z8 with bimanual phacoemulsification, Cavallini et al. [14] did not observe any intraoperative complications, either in the phacoemulsification group or in the group with the low-energy Ziemer FEMTO LDV Z8.

Based on the results of our study, capsular tears may be expected in 0.28% of cases. These findings underline that the use of this method does not cause many intraoperative complications and is accordingly in line with results reported in the literature [3, 23, 25]. Our results emphasize that an accurate and circular capsulotomy has low risk for an intraoperative complication.

Learning curve

In reviewing the literature, we found that the use of the FLACS technique entails a learning curve [26]. Several studies have indicated increased safety after a learning curve [2729]. Roberts et al. [28] confirmed that the incidence of anterior and posterior capsular rupture decreased significantly with the number of performed surgeries, decreasing from 7.5% in the first 200 cases to 0.62% in the last 1,300 cases. Cavallini et al. [29] also observed an initial learning curve: for the first 60 FLACS, the intraoperative complication rate was 18.3%, whereas it was 3.3% for the following 60 FLACS cases. Nagy et al. [30] showed that most complications in FLACS occurred principally during the first 100 surgeries. We took this learning curve into account by excluding the first 20 operations of each surgeon in our study. Nevertheless, even if the first 20 operations of the two surgeons were included in our study, the complication rate would hardly change: 0.28% (5/1,806)–0.38% (7/1,846). It should not go unmentioned that an exclusion of up to 100 cases would not have changed the number of complications in our study. The first complication after the learning curve occurred in surgery 106. This indicates a potentially shorter learning curve with the low-energy laser as opposed to the high-energy technology.

Conclusions

FLACS allows tissue to be cut with a very high precision inside the eye. In our study, we were able to demonstrate a low intraoperative complication rate of 0.28% in a high-volume single-surgical center setting using a low-energy femtosecond laser in the hands of two experienced cataract surgeons. Specifically, anterior capsule tears occurred in 0.17% of cases and posterior capsule ruptures in 0.11% of cases. We believe that this is related to the low-energy technology, which results in virtually no collateral damage adjacent to the laser spots and thereby improves precision and safety of the procedure. However, this hypothesis must be validated by further investigations, especially on comparative complication data between femtosecond laser-assisted and conventional cataract surgery in the hands of the same surgeon. Despite this, insights must be validated in an even larger sample size with a matched control group. More studies comparing high- with low-energy concepts are needed.

Supporting information

S1 File

(XLSX)

Data Availability

All relevant data are within the paper and its Supporting information file.

Funding Statement

This work was supported by a research grant by Ziemer Ophthalmic System AG, Port, Switzerland (https://www.ziemergroup.com/en/contact/addresses-and-locations/ziemer-ophthalmic-systems-ag/) The funders had no role in study design, data collection and analysis and decision to publish. The funders reviewed manuscript.

References

  • 1.Sharma B, Abell RG, Arora T, Antony T, Vajpayee RB. Techniques of anterior capsulotomy in cataract surgery. Indian J Ophthalmol. 2019;67(4):450–60. doi: 10.4103/ijo.IJO_1728_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Qian DW, Guo HK, Jin SL, Zhang HY, Li YC. Femtosecond laser capsulotomy versus manual capsulotomy: a Meta-analysis. Int J Ophthalmol. 2016;9(3):453–8. doi: 10.18240/ijo.2016.03.23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Latz C, Asshauer T, Rathjen C, Mirshahi A. Femtosecond-Laser Assisted Surgery of the Eye: Overview and Impact of the Low-Energy Concept. Micromachines (Basel). 2021;12(2). doi: 10.3390/mi12020122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dick HB, Schultz T. A Review of Laser-Assisted Versus Traditional Phacoemulsification Cataract Surgery. Ophthalmol Ther. 2017;6(1):7–18. doi: 10.1007/s40123-017-0080-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Vogel A, Busch R. Shock wave emission and cavitation bubble generation by picosecond and nanosecond optical breakdown in water. J Acoust Soc Am [Internet]. 1996; 100(1):[148–65 pp.]. [Google Scholar]
  • 6.Tinne N, Knoop G, Kallweit N, Veith S, Bleeker S, Lubatschowski H, et al. Effects of cavitation bubble interaction with temporally separated fs-laser pulses. J Biomed Opt. 2014;19(4):048001. [DOI] [PubMed] [Google Scholar]
  • 7.Lubatschowski H, Maatz G, Heisterkamp A, Hetzel U, Drommer W, Welling H, et al. Application of ultrashort laser pulses for intrastromal refractive surgery. Graefes Arch Clin Exp Ophthalmol. 2000;238(1):33–9. doi: 10.1007/s004170050006 [DOI] [PubMed] [Google Scholar]
  • 8.Kaschke M, DonnerhackeK.-H., Rill MS. Optical Devices in Ophthalmology and Optometry: Technology, Design Principles and Clinical Applications.: WILEY-VCH Verlag GmbH & Co. KGaA; 2014.
  • 9.Lubatschowski H. Overview of commercially available femtosecond lasers in refractive surgery. J Refract Surg. 2008;24(1):S102–7. doi: 10.3928/1081597X-20080101-18 [DOI] [PubMed] [Google Scholar]
  • 10.Popovic M, Campos-Möller X, Schlenker MB, Ahmed II. Efficacy and Safety of Femtosecond Laser-Assisted Cataract Surgery Compared with Manual Cataract Surgery: A Meta-Analysis of 14 567 Eyes. Ophthalmology. 2016;123(10):2113–26. [DOI] [PubMed] [Google Scholar]
  • 11.Mirshahi A, K AP. Changes in Pupil Area during Low-energy Femtosecond Laser-assisted Cataract Surgery. J Ophthalmic Vis Res. 2019;14(3):251–6. doi: 10.18502/jovr.v14i3.4780 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Schwarzenbacher L, Schartmuller D, Leydolt C, Menapace R. Intraindividual comparison of cytokine and prostaglandin levels with and without low-energy, high-frequency femtosecond laser cataract pretreatment after single-dose topical NSAID application. J Cataract Refract Surg. 2020;46(8):1086–91. doi: 10.1097/j.jcrs.0000000000000221 [DOI] [PubMed] [Google Scholar]
  • 13.Lin HY, Chuang YJ, Lin PJ. Surgical outcomes with high and low pulse energy femtosecond laser systems for cataract surgery. Sci Rep. 2021;11(1):9525. doi: 10.1038/s41598-021-89046-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cavallini GM, Fornasari E, De Maria M, Lazzerini A, Campi L, Verdina T. Bimanual femtosecond laser-assisted cataract surgery compared to standard bimanual phacoemulsification: A case-control study. Eur J Ophthalmol. 2019;29(6):629–35. doi: 10.1177/1120672118805323 [DOI] [PubMed] [Google Scholar]
  • 15.Pajic B, Cvejic Z, Pajic-Eggspuehler B. Cataract Surgery Performed by High Frequency LDV Z8 Femtosecond Laser: Safety, Efficacy, and Its Physical Properties. Sensors (Basel). 2017;17(6). doi: 10.3390/s17061429 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pajic B, Vastardis I, Gatzioufas Z, Pajic-Eggspuehler B. First experience with the new high-frequency femtosecond laser system (LDV Z8) for cataract surgery. Clin Ophthalmol. 2014;8:2485–9. doi: 10.2147/OPTH.S72983 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kolb CM, Shajari M, Mathys L, Herrmann E, Petermann K, Mayer WJ, et al. Comparison of femtosecond laser-assisted cataract surgery and conventional cataract surgery: a meta-analysis and systematic review. J Cataract Refract Surg. 2020;46(8):1075–85. doi: 10.1097/j.jcrs.0000000000000228 [DOI] [PubMed] [Google Scholar]
  • 18.Abell RG, Davies PEJ, Phelan D, Goemann K, McPherson ZE, Vote BJ. Anterior capsulotomy integrity after femtosecond laser-assisted cataract surgery. Ophthalmology. 2014;121(1):17–24. doi: 10.1016/j.ophtha.2013.08.013 [DOI] [PubMed] [Google Scholar]
  • 19.Mayer WJ, Klaproth OK, Ostovic M, Terfort A, Vavaleskou T, Hengerer FH, et al. Cell death and ultrastructural morphology of femtosecond laser-assisted anterior capsulotomy. Invest Ophthalmol Vis Sci. 2014;55(2):893–8. doi: 10.1167/iovs.13-13343 [DOI] [PubMed] [Google Scholar]
  • 20.Toto L, Calienno R, Curcio C, Mattei PA, Mastropasqua A, Lanzini M, et al. Induced inflammation and apoptosis in femtosecond laser-assisted capsulotomies and manual capsulorhexes: an immunohistochemical study. J Refract Surg. 2015;31(5):290–4. doi: 10.3928/1081597X-20150423-01 [DOI] [PubMed] [Google Scholar]
  • 21.Pisciotta A, De Maria M, Verdina T, Fornasari E, de Pol A, Cavallini GM. Anterior Capsule of the Lens: Comparison of Morphological Properties and Apoptosis Induction following FLACS and Standard Phacoemulsification Surgery. Biomed Res Int. 2018;2018:7242837. doi: 10.1155/2018/7242837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Williams GP, George BL, Wong YR, Yam GHF, Ang M, Tay SC, et al. Performing Reliable Lens Capsulotomy in the Presence of Corneal Edema With a Femtosecond Laser. Invest Ophthalmol Vis Sci. 2017;58(11):4490–8. doi: 10.1167/iovs.17-22227 [DOI] [PubMed] [Google Scholar]
  • 23.Wang J, Su F, Wang Y, Chen Y, Chen Q, Li F. Intra and post-operative complications observed with femtosecond laser-assisted cataract surgery versus conventional phacoemulsification surgery: a systematic review and meta-analysis. BMC Ophthalmol. 2019;19(1):177. doi: 10.1186/s12886-019-1190-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chen M, Swinney C, Chen M. Comparing the intraoperative complication rate of femtosecond laser-assisted cataract surgery to traditional phacoemulsification. Int J Ophthalmol. 2015;8(1):201–3. doi: 10.3980/j.issn.2222-3959.2015.01.34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Manning S, Barry P, Henry Y, Rosen P, Stenevi U, Young D, et al. Femtosecond laser-assisted cataract surgery versus standard phacoemulsification cataract surgery: Study from the European Registry of Quality Outcomes for Cataract and Refractive Surgery. J Cataract Refract Surg. 2016;42(12):1779–90. doi: 10.1016/j.jcrs.2016.10.013 [DOI] [PubMed] [Google Scholar]
  • 26.Han SB, Liu YC, Mohamed-Noriega K, Mehta JS. Application of Femtosecond Laser in Anterior Segment Surgery. J Ophthalmol. 2020;2020:8263408. doi: 10.1155/2020/8263408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bali SJ, Hodge C, Lawless M, Roberts TV, Sutton G. Early experience with the femtosecond laser for cataract surgery. Ophthalmology. 2012;119(5):891–9. doi: 10.1016/j.ophtha.2011.12.025 [DOI] [PubMed] [Google Scholar]
  • 28.Roberts TV, Lawless M, Bali SJ, Hodge C, Sutton G. Surgical outcomes and safety of femtosecond laser cataract surgery: a prospective study of 1500 consecutive cases. Ophthalmology. 2013;120(2):227–33. doi: 10.1016/j.ophtha.2012.10.026 [DOI] [PubMed] [Google Scholar]
  • 29.Cavallini GM, Verdina T, De Maria M, Fornasari E, Volpini E, Campi L. Femtosecond laser-assisted cataract surgery with bimanual technique: learning curve for an experienced cataract surgeon. Int Ophthalmol. 2019;39(1):1–9. doi: 10.1007/s10792-017-0776-z [DOI] [PubMed] [Google Scholar]
  • 30.Nagy ZZ, Takacs AI, Filkorn T, Kranitz K, Gyenes A, Juhasz E, et al. Complications of femtosecond laser-assisted cataract surgery. J Cataract Refract Surg. 2014;40(1):20–8. doi: 10.1016/j.jcrs.2013.08.046 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Rajiv Janardhanan

8 Aug 2022

PONE-D-22-10143Intraoperative complications of cataract surgery using a low-energy femtosecond laser: Results from a real-world high-volume settingPLOS ONE

Dear Dr.Julia Riemey:

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. Abbreviations used in the manuscript has not been mentioned with their relevant word or phrase

2. The manuscript is written with poor grammar and spelling mistakes which minimizes the overall quality.

Reviewer #2: The study underlines the safety of low-energy femtosecond assisted cataract surgery in a real-world setting. The manuscript is well written , designed and analyzed. The concept of cataract surgery using low-energy lasers are still very sparse. This study reported data on intraoperative complications of cataract surgery using a low-energy

46 femtosecond laser in a high-volume single-center setting in Bonn, Germany.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Please submit your revised manuscript by Sep 22 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Rajiv Janardhanan, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Competing Interests section: 

I have read the journal's policy and the authors of this manuscript have the following competing interests: AM is a consultant to Ziemer Ophthalmics, Port, Switzerland.

Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. 

Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 15;17(12):e0279023. doi: 10.1371/journal.pone.0279023.r002

Author response to Decision Letter 0


29 Sep 2022

Dear Reviewer

thank you very much for your effort and review of this paper. Please find enclosed our revised manuscript titled “Intraoperative complications of cataract surgery using a low-energy femtosecond laser: Results from a real-world high-volume setting”.

Following the suggestions of Reviewer #2, we have developed and expanded the concept of cataract surgery using low-energy lasers. The low-energy-concept is now carried out in detail.

Following the comments of Reviewer #1, we carefully reworked our abbreviations used in the manuscript. Mentioned abbreviations are now explained with their first use.

The revised manuscript has subsequently been carefully reviewed by an experienced editor whose first language is English and who specializes in editing papers written by scientists whose native language is not English.

We look forward to hearing from you at your earliest convenience.

Sincerely,

Julia Riemey

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Rajiv Janardhanan

25 Oct 2022

PONE-D-22-10143R1Intraoperative complications of cataract surgery using a low-energy femtosecond laser: Results from a real-world high-volume settingPLOS ONE

Dear Dr. Julia Riemey:

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Reviewer #1: The manuscript has been well written but the reference number are not in the order. Kindly arrange the references in the manuscript in the systematic fashion.

==============================

Please submit your revised manuscript by 02 November 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Rajiv Janardhanan, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript has been well written but the reference number are not in the order. Kindly arrange the references in the manuscript in the systematic fashion.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 15;17(12):e0279023. doi: 10.1371/journal.pone.0279023.r004

Author response to Decision Letter 1


1 Nov 2022

Dear Reviewer

thank you very much for your effort and review of this paper. Please find enclosed our revised manuscript titled “Intraoperative complications of cataract surgery using a low-energy femtosecond laser: Results from a real-world high-volume setting”.

Following the comments of Reviewer #1, we arranged the references in the manuscript in the systematic fashion. The reference numbers are now in the right order.

We look forward to hearing from you at your earliest convenience.

Sincerely,

Julia Riemey

Attachment

Submitted filename: Response to Reviewers.pdf

Decision Letter 2

Rajiv Janardhanan

29 Nov 2022

Intraoperative complications of cataract surgery using a low-energy femtosecond laser: Results from a real-world high-volume setting

PONE-D-22-10143R2

Dear Dr.HOUDA ZAHFIR

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Rajiv Janardhanan, Ph.D.

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Acceptance letter

Rajiv Janardhanan

6 Dec 2022

PONE-D-22-10143R2

Intraoperative complications of cataract surgery using a low-energy femtosecond laser: Results from a real-world high-volume setting

Dear Dr. Riemey:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Rajiv Janardhanan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.pdf

    Data Availability Statement

    All relevant data are within the paper and its Supporting information file.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES